These success, along with a previous report demonstrating that a little-molecule ACKR3 agonist CCX771 reveals anxiolytic-like conduct in mice,2 help the strategy of focusing on ACKR3 as a novel approach to modulate the opioid program, which could open new therapeutic avenues for opioid-similar disorders. Researchers think that blocking this https://aristotlek357jcz3.blog-mall.com/profile